Emerging Trends in Cancer Genomics
This session
highlights recent discoveries in cancer genomics, from driver mutations to tumour
mutational burden and neoantigen prediction. Experts will discuss multi-omics
approaches, epigenomics, and liquid
biopsy applications. The session aims
to translate genetic discoveries into actionable therapeutic strategies and
personalised treatment plans. It will also explore the future of precision oncology driven by real-time
genomic data.
Subtracks:
- Tumour Genomic Profiling and Biomarker Discovery
- Multi-Omics Approaches in Cancer Research
- Liquid Biopsy for Real-Time Tumour Monitoring
- Neoantigen Prediction for Personalised Immunotherapy
- Cancer Epigenomics and Methylation Markers
- AI in Genomic Data Interpretation